Get started
Author

Anya Jafari

Observed names: Jafari, Anya, anya jafari
ORCID: 0000-0001-7175-0034
Observed ORCID: 0000-0001-7175-0034
OpenAlex ID: A5042158679
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
2020 · Anya Jafari, Sahar Dadkhahfar, et al. · Critical Reviews in Oncology/Hematology · 27
Association of immunohistochemical markers of tumor subtype with response to neoadjuvant chemotherapy and survival in patients with muscle-invasive bladder cancer
2021 · Abolfazl Razzaghdoust, Mahdi Ghajari, et al. · Korean journal of urology · 20
Fertility of Hydatid Cysts and Viability of Protoscoleces in Slaughtered Animals in Qazvin, Iran
2012 · Mojtaba Shahnazi, Anya Jafari, et al. · Journal of Agricultural Science · 11
Primary Prostate Lymphoma Managed with Combined Modality Treatment: A Case Report.
2019 · Anya Jafari, Bahram Mofid, et al. · Urology journal./Urology jornal. · 6
PDF
Diffusion-weighted MRI-Derived ADC and tumor volume as predictive imaging markers for neoadjuvant chemotherapy response in muscle-invasive bladder cancer
2025 · Abolfazl Razzaghdoust, Anya Jafari, et al. · BMC Medical Imaging · 5
PDF
Simultaneous development of COVID-19 pneumonia and pulmonary metastasis in a known case of chondrosarcoma: a case report
2021 · Afshin Rakhsha, Zahra Mahboubi-Fooladi, et al. · Journal of Medical Case Reports · 4
PDF
An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis
2021 · Anya Jafari, Zahra Siavashpour, et al. · International Journal of Cancer Management · 4
PDF
Top cited publications for treatment of keloid with radiotherapy: A Bibliometric analysis
2023 · Zahra Siavashpour, Mohammad Houshyari, et al. · Journal of Cancer Research and Therapeutics · 2
Machine learning-based radiomics using magnetic resonance images for prediction of clinical complete response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
2025 · Bahram Mofid, Hamid Abdollahi, et al. · The Egyptian Journal of Radiology and Nuclear Medicine · 1
PDF
Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis.
2022 · Bahram Mofid, Abolfazl Razzaghdoust, et al. · PubMed · 1
Incidence of Seminoma Cancer in Staffs that Worked in Electromagnetic Waves Station; Three Cases Report.
2015 · Mohammad Houshyari, Anya Jafari, et al. · PubMed · 1
Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort study
2026 · Bahram Mofid, Anya Jafari, et al. · BMC Urology
MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Benyamin Khajetash, Bahareh Hatami, et al. · The Egyptian Journal of Radiology and Nuclear Medicine
PDF
Additional file 8 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 6 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 9 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 3 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 10 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 5 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 7 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 1 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 4 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Additional file 2 of MRI delta-radiomics for prediction of tumor response in muscle-invasive bladder cancer patients undergoing neoadjuvant chemotherapy
2026 · Khajetash, Benyamin, Hatami, Bahareh, et al. · Figshare
Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance
2024 · Fatemeh Zahedi, Anya Jafari, et al. · Expert Opinion on Drug Safety
Works count: 37
Citation count: 82
H-index: 5
I10-index: 3
Year
Topic
Type